T1	intervention 0 27	Partial-breast radiotherapy
T4	age 795 812	50 years or older
T5	location 780 782	UK
T6	eligibility 813 1077	who had undergone breast-conserving surgery for unifocal invasive ductal adenocarcinoma of grade 1-3, with a tumour size of 3 cm or less (pT1-2), none to three positive axillary nodes (pN0-1), and minimum microscopic margins of non-cancerous tissue of 2 mm or more
T7	control 1146 1187	40 Gy whole-breast radiotherapy (control)
T8	outcome-Measure 1783 1808	ipsilateral local relapse
T10	total-participants 2302 2306	2018
T11	control-participants 2395 2398	674
T12	intervention-participants 2472 2475	673
T13	intervention-participants 2507 2510	669
T15	cv-bin-percent 2654 2658	1·1%
T16	iv-bin-percent 2710 2714	0·2%
T17	iv-bin-percent 2757 2761	0·5%
T2	outcome 2842 2855	local relapse
T3	outcome 2614 2648	local relapse cumulative incidence
T9	outcome 3834 3847	local relapse
T14	outcome 3351 3366	adverse effects
T18	outcome 3509 3536	change in breast appearance
T19	outcome 3570 3593	breast harder or firmer
